Westlake, LA, April 14, 2021 - - Epidemiologic Solutions Corporation (ESC), a public charity qualified by the Internal Revenue Service pursuant to Section 501(c)(3) commits not less than $200,000 of funding to Gold River Productions Services (OTC Pink: GRPS) for its development of PainplexTM an all-herbal extraction developed by Gold River Productions Services (GRPS) and other formulations. This will be part of the “Relief Kit,” which will include products from both GRPS and Halberd...
NEWSROOM
Pandemic
The Pandemic is a Long-Term Factor (NASDAQ: QDEL) (NYSEAMERICAN: APT) (OTC US: BNOW) (NYSE: ABT)
The pandemic won’t always be a pandemic, but the virus is going to with us as an endemic part of life. That’s the message from a new piece on Reuters. Reuters interviewed 18 virus specialists working on the pandemic. According to the piece, the specialists were hopeful that we would be able to totally eradicate Covid-19 after we started to get strong data on how effective the Pfizer and Moderna vaccines were in November and December. However, recent data emerging from new variants in South...
Stocks for the Pandemic Long Haul (NASDAQ: FLGT) (OTC US: ALST) (NASDAQ: HOLX)
Scientists are beginning to arrive at the notion that the fight with Covid-19 is not a short raging battle that will be over by summer 2021 but a long-term war that will be waged for many years to come, with a constant need for PPE, testing, vaccine rejiggering, specialized air filtration solutions, and other ‘coping’ tools and resources. Of all of these concepts, aside from vaccines, the most important may end up being rapid testing solutions. With that in mind, we take a look at a few of the...
WSGF Vaycaychella Fintech App Could Fuel Post Vaccine Real Estate Market
Dallas, Texas , January 13, 2021 - World Series of Golf, Inc. (OTC PINK: WSGF) ("WSGF") today highlighted an article from Motley Fool: How Real Estate Investors Can Capitalize on a Post-Vaccine Market Now WSGF has recently entered and set its primary focus on the short-term vacation rental market through the acquisition of Vaycaychella. Vaycaychella plans to beta launch a peer-to-peer (P2P) application (app) to automate the connection of short-term rental property buyers with alternative...
Immune Therapeutics, Inc. to Collaborate with Cytocom, Inc. to Develop Therapies for COVID-19. Immune Therapeutics, Inc. Signs Binding Letter of Intent to Collaborate with Cytocom, Inc. to Develop Lodonal™ and Other Drugs for COVID-19; Other Drug Development Programs Also Moving Forward
ORLANDO, Florida, March 20, 2020 – Immune Therapeutics, Inc. (OTC PINK: IMUN) (“Immune” “IMUN” or the “Company”), Immune Therapeutics, Inc., a late-stage clinical biopharmaceutical company focused on the development and commercialization of highly innovative therapies for use in oncology, immunology and anti-inflammatory disease today announced the signing of a binding letter of intent to collaborate with Cytocom, Inc. (“Cytocom” or “CYTO”) for the development of Lodonal™ and IRT-101 for use...